Forward Pharma A/S
FWPAY · OTC
6/30/2022 | 12/31/2021 | 6/30/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $36,663 | $47,758 | $68,797 | $55,699 |
| - Cash | $65,275 | $70,770 | $75,097 | $79,087 |
| + Debt | $2,945 | $0 | $0 | $0 |
| Enterprise Value | -$25,667 | -$23,012 | -$6,300 | -$23,388 |
| Revenue | – | – | – | – |
| % Growth | – | – | – | – |
| Gross Profit | – | – | – | – |
| % Margin | – | – | – | – |
| EBITDA | – | – | – | – |
| % Margin | – | – | – | – |
| Net Income | – | – | – | – |
| % Margin | – | – | – | – |
| EPS Diluted | – | – | – | – |
| % Growth | – | – | – | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |